Table 2.
Laboratory data of studied subjects
| |
Cases
|
Control
|
P
|
|---|---|---|---|
| (n = 80) | (n = 40) | ||
|
Serum Ca (mg/dL) |
8.5 ± 1.6 |
10 ±1.4 |
<0.01a |
|
Serum Po4 (mg/dL) |
5.4 ± 1.5 |
3.6 ± 0.9 |
<0.01a |
|
Serum Alkaline phosphatase (IU/L) |
200(44–453) |
189(68–451) |
> 0.05b |
|
Fasting blood Glucose (mg/dL) |
178(112–316) |
94(80–133) |
<0.01b |
|
Fasting insulin (uU/mL) |
5.2 ± 1.9 |
6.7 ± 2.3 |
< 0.05a |
|
Insulin dose (U/Kg/d) |
0.9 ± 0.1 |
- |
|
|
HbA1c (%) |
8.6 ± 1.9 |
- |
|
|
HOMA-IR |
3.5 ± 0.7 |
1.4 ± 0.3 |
<0.01a |
|
Serum 25 OH Vit D (ng/ml) |
24.7 ± 5.6 |
26.5 ± 4.8 |
> 0.05a |
| Serum PTH (pg/ml) | 57.7 ± 13.2 | 33.3 ± 8.3 | <0.01a |
HbA1c: glycosylated hemoglobin; HOMA-IR: Homeostasis model for assessment of insulin resistance; Serum PTH: serum parathyroid hormone.
Data are presented as mean ± SD or median (min-max).
P value < 0.05 indicates a significant difference.
a(Student t-test). bMann–Whitney U test.